Lanean...
In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
Cowpea mosaic virus (CPMV) is currently in the development pipeline for multiple biomedical applications, including cancer immunotherapy. In particular the application of CPMV as in situ vaccine has shown promise; here the plant viral nanoparticle is used as an adjuvant and is injected directly into...
Gorde:
| Argitaratua izan da: | Mater Adv |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
RSC
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323807/ https://ncbi.nlm.nih.gov/pubmed/34368764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0ma00752h |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|